Skip to main content
Veritas In Silico Inc. logo

Veritas In Silico Inc. — Investor Relations & Filings

Ticker · 130A ISIN · JP3155340007 T Professional, scientific and technical activities
Open in API
Filings indexed 18 across all filing types
Latest filing 2026-03-23 Regulatory Filings
Country JP Japan
Listing T 130A

About Veritas In Silico Inc.

https://www.veritasinsilico.com/

Veritas In Silico Inc. is a drug discovery company that specializes in developing therapeutics targeting messenger RNA (mRNA). The company utilizes its proprietary, AI-driven integrated drug discovery platform, ibVIS®, for in silico target identification and high-throughput screening. Its primary focus is on creating innovative small molecule drugs and nucleic acid medicines. Veritas In Silico operates through a collaborative business model, engaging in joint research and development partnerships with pharmaceutical companies to discover and develop novel treatments for various diseases.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 75% confidence The document is a “確認書” (confirmation statement) submitted to the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act, confirming the accuracy of the annual securities report (“有価証券報告書”). It is not the securities report itself (10-K equivalent) but a supporting regulatory submission. It does not fit any specific category such as an earnings release, management change, or dividend notice, so it falls under the general regulatory filings fallback category (RNS).
2026-03-23 Japanese
有価証券報告書－第10期(2025/01/01－2025/12/31)
Annual Report Classification · 100% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which translates to 'Annual Securities Report'. This is the standard Japanese regulatory filing equivalent to the US 10-K, containing comprehensive financial statements, business descriptions, and management analysis for the fiscal year ending December 31, 2025. It is a formal, long-form regulatory document, not an announcement or a summary. FY 2025
2026-03-23 Japanese
半期報告書－第10期(2025/01/01－2025/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) filed by Veritas In Silico Inc. in Japan. It contains detailed financial statements (balance sheet, income statement) for the interim period from January 1, 2025, to June 30, 2025, and includes management analysis and corporate information. This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. H1 2025
2025-08-14 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act. It serves as an officer certification regarding the accuracy of a semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type like an interim/semi-annual report. H1 10
2025-08-14 Japanese
臨時報告書
AGM Information Classification · 100% confidence The document is titled '臨時報告書' (Extraordinary Report) and is submitted to the Kanto Local Finance Bureau. Section 1 explicitly states the reason for filing is that resolutions were passed at the '定時株主総会' (Annual General Meeting) held on March 27, 2025, citing regulations related to disclosure. Section 2 details the resolutions passed, including capital reduction, articles of incorporation changes, and the election of directors and a substitute auditor. The core content is the official results of shareholder voting (votes for, against, abstentions) from a general meeting. This strongly indicates a filing reporting the outcome of a shareholder vote. The most specific category for official results from shareholder votes is 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it relates to an AGM, the document's purpose is the formal reporting of the vote results, not the AGM presentation itself (AGM-R) or the proxy materials (PSI).
2025-03-28 Japanese
内部統制報告書－第9期(2024/01/01－2024/12/31)
Audit Report / Information Classification · 98% confidence The document header explicitly states the filing type as "【提出書類】 内部統制報告書" (Filing Document: Internal Control Report) and cites the legal basis as "金融商品取引法第24条の４の４第１項" (Article 24-4-4, Paragraph 1 of the Financial Instruments and Exchange Act). The content discusses the framework, scope, criteria, and results of the assessment of internal controls over financial reporting, concluding that the internal controls are effective as of the end of the business year (December 31, 2024). This directly corresponds to the requirements for an Audit Report / Information filing, specifically concerning internal control assessments, which aligns best with the 'AR' (Audit Report / Information) code among the provided options, as it is a formal report on internal controls, distinct from a full Annual Report (10-K) or a simple Earnings Release (ER). FY 2024
2025-03-28 Japanese

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.